Search hospitals > New York > New Hyde Park
Clinical Research Alliance
Claim this profileNew Hyde Park, New York 11042
Global Leader in Lymphoma
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Follicular Lymphoma
68 reported clinical trials
2 medical researchers
Summary
Clinical Research Alliance is a medical facility located in New Hyde Park, New York. This center is recognized for care of Lymphoma, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Follicular Lymphoma and other specialties. Clinical Research Alliance is involved with conducting 68 clinical trials across 86 conditions. There are 2 research doctors associated with this hospital, such as Morton MD Coleman, doctor and James T D'Olimpio, MD.Area of expertise
1Lymphoma
Global LeaderStage II
CD20 positive
Stage III
2Breast Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Morton MD Coleman, doctorClinical Research Alliance9 years of reported clinical research
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
12 reported clinical trials
26 drugs studied
James T D'Olimpio, MDClinical Research Alliance1 year of reported clinical research
Studies Lymphoma
Studies Leukemia
14 reported clinical trials
33 drugs studied
Clinical Trials running at Clinical Research Alliance
Breast Cancer
Lymphoma
Follicular Lymphoma
Non-Small Cell Lung Cancer
Lung Cancer
Marginal Zone Lymphoma
Small Cell Lung Cancer
Chronic Lymphocytic Leukemia
Chronic B-Cell Leukemia
Mantle Cell Lymphoma
Giredestrant + Phesgo
for Breast Cancer
This trial is testing whether a combination of two drugs is more effective than one drug for patients with advanced breast cancer. The drugs work by blocking signals that help cancer cells grow. The study focuses on patients whose cancer cannot be cured with surgery or other local treatments.
Recruiting2 awards Phase 311 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Clinical Research Alliance?
Clinical Research Alliance is a medical facility located in New Hyde Park, New York. This center is recognized for care of Lymphoma, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Follicular Lymphoma and other specialties. Clinical Research Alliance is involved with conducting 68 clinical trials across 86 conditions. There are 2 research doctors associated with this hospital, such as Morton MD Coleman, doctor and James T D'Olimpio, MD.